Company Overview
- Website
- aperturagtx.com
- Employees
- 21
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Recent News & Media
Apertura Gene Therapy Showcases the Progress of its Novel Human Transferrin Receptor AAV Capsid, TfR1 CapX, and Preclinical Programs for Tuberous Sclerosis Complex (TSC) at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
- May 7, 2025
- prnewswire.com
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
- Apr 30, 2025
- prnewswire.com
The biotech bi-weekly: accelerating antibody discovery, developing gene therapy for prion disease and advancing genomic medicine
- Mar 12, 2025
- biotechniques.com
Merging technologies to cure prion diseases
- Mar 11, 2025
- scientistlive.com
Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery
- Feb 28, 2025
- prnewswire.com
Apertura and Atalanta reduce headcount en route toward the clinic
- Oct 18, 2024
- endpoints.news
Who is Apertura Gene Therapy
Apertura Gene Therapy is a biotechnology company based in New York City. Founded on innovations originating from the Broad Institute and Harvard University, the company is fueled by a small team of 21 dedicated professionals. With backing from Deerfield Management Company, Apertura is focused on developing next-generation gene therapies. Apertura specializes in engineering adeno-associated virus (AAV) gene therapies. Their innovative approach involves simultaneously modifying the capsid, regulatory elements, and payloads to address the current limitations of genetic medicine. This technology aims to provide new treatment options for debilitating diseases that currently have limited therapeutic choices. Apertura's commitment to scientific advancement is evident in their collaboration with prominent research institutions. Their therapies leverage cutting-edge research from the Broad Institute and Harvard University, pushing the boundaries of gene therapy possibilities. To learn more about Apertura Gene Therapy's groundbreaking work, visit their website at aperturagtx.com.
Company Leadership
Apertura Gene Therapy Industry Tags
Companies Similar to Apertura Gene Therapy
Analyze industry trends and opportunities by examining competitors and companies comparable to Apertura Gene Therapy, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |